ABEC Bioreactor Systems to Support Ongoing Expansion of Qilu’s Biopharmaceutical Production Capacity Bethlehem, PA, USA – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced Qilu Pharmaceutical Co. has again selected ABEC to rapidly expand production capacity at their cGMP manufacturing facility in Jinan, Shandong, China. ABEC is delivering several sets of […]

Now Commercially Available, Both NextSeq 1000 and NextSeq 2000 Sequencers Include Integrated Informatics and Loss-less Compression Technology, Creating an Intuitive User Experience SAN DIEGO — . Illumina, Inc. (NASDAQ: ILMN) is further extending the reach of the NextSeq™ 2000 Sequencing System with the commercial availability of the P3 high-output flow cell. The P3 flow cell offers 1.1 billion […]

Customized cell analyzer installed in Naples, Italy for biomedical research and water monitoring MOUNTAIN VIEW, Calif. — Kinetic River Corporation, a leader in custom flow cytometry instrumentation, announced today the delivery of its flagship Potomac customizable flow cytometer to the National Research Council in Naples, Italy. The Potomac flow cytometer was installed by CytoFlowService/EMC2, Kinetic River’s distribution and service partners for Europe, in […]

ABEC’s fermentation systems to support growing demand for recombinant proteins for biotechnology research Bethlehem, PA, USA, November 9, 2020, ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced New England Biolabs® (NEB®) selected ABEC to expand production capacity at their manufacturing facilities in Ipswich and Rowley, MA. NEB, an international leader in the discovery and […]

Companies to co-develop a first-of-its-kind, single-use flow-through polishing system for GMP operation Merck’s continuous processing expertise to accelerate Transcenta’s development, implementation of continuous bioprocessing platform Collaboration expected to accelerate affordable access to therapeutics for patients in China and globally Shanghai, China – Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing […]

Companies to co-develop a first-of-its-kind, single-use flow-through polishing system for GMP operation MilliporeSigma’s continuous processing expertise to accelerate Transcenta’s development, implementation of continuous bioprocessing platform Collaboration expected to accelerate affordable access to therapeutics for patients in China and globally Shanghai, China — MilliporeSigma, a leading science and technology company, and Transcenta, a global biotherapeutics company, […]

Joint venture expands global pharma services capacity for drug development and manufacturing WALTHAM, Mass. and SHANGHAI — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and […]

Virtual ground-breaking of the expanded manufacturing facility of consumables; Strategic partnership with Zhifei Longcom Biologic Pharmacy to improve process of vaccine development; Accelerated collaboration with Clover Biopharmaceuticals to support the scale-up of its protein-based COVID-19 S-Trimer subunit vaccine candidate; Joint lab to be set up with Jinbo Bio-Pharmaceutical to advance industry innovation. Cytiva, a global […]

New RNA Spatial Profiling Service Allows Researchers to Access Advanced Technology and Extensive RNA Expertise in a Commercial Lab Setting MOUNTAIN VIEW, Calif.— Cellecta, Inc. today announced the launch of its new RNA Spatial Profiling Service using NanoString’s GeoMx®Cancer Transcriptome Atlas (CTA) on the GeoMx Digital Spatial Profiler. As one of the few designated GeoMx […]

Company’s Innovative Spectral Cell Analysis Systems Fueling Advancements in Immunotherapy, Infectious Disease Research FREMONT, Calif. — Cytek Biosciences Inc., a leading provider of cell analysis instrumentation and solutions, today announced that it has closed a $120 million Series D funding round, co-led by RA Capital and Hillhouse Capital, with OrbiMed and LYFE Capital also participating. The investment will be used to expand Cytek’s […]